Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis

✍ Scribed by K. Kontou-Fili; C. I. Filis

• Book ID: 110886836
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 751 KB
• Volume: 64
• Category: Article
• ISSN: 0105-4538
• DOI: 10.1111/j.1398-9995.2009.02045.x